Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-03
1995-02-28
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546123, A61K 31435, C07D47104
Patent
active
053937589
ABSTRACT:
The present invention relates to new azetidine derivatives of substituted azetidinylpyridonecarboxylic acids, of 1,4-dihydro-4-oxo-3-quinolinecarboxylic, 4-oxo-1,8-naphthyridine-3-carboxylic and 2,3-dihydro-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acids, represented by the general formula I: ##STR1## The present invention also relates to therapeutically acceptable salts of these compounds, a process for preparing them and their application as medicinal products.
REFERENCES:
patent: 4777175 (1988-10-01), Culbertson et al.
patent: 4997943 (1991-03-01), Iwata et al.
patent: 5039683 (1991-08-01), Nakanishi
Egawa et al., J. Med. Chem. v. 27, pp. 1543-48 (1984).
Constansa Jordi F.
Corominas Juan P.
Pinol Augusto C.
Dentz Bernard
Laboratorios del Dr. Esteve S.A.
LandOfFree
Substituted azetidinylpyridone naphthyridine carboxylic acid der does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted azetidinylpyridone naphthyridine carboxylic acid der, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted azetidinylpyridone naphthyridine carboxylic acid der will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-848651